MEIP
Price:
$2.42
Market Cap:
$16.12M
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase 9 inhibitor, which is in Phase Ib clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex that is in Phase I clinical tr...[Read more]
Industry
Biotechnology
IPO Date
2003-12-18
Stock Exchange
NASDAQ
Ticker
MEIP
According to MEI Pharma, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of -100.00% compared to the average of 18.83% of the last 4 quarters.
The mean historical Dividend Yield of MEI Pharma, Inc. over the last ten years is 6.14%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), MEIP's Dividend Yield was at its highest in in the March 2024 quarter at 45.12%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.
Average
6.14%
Median
0%
Minimum
0%
Maximum
61.40%
Discovering the peaks and valleys of MEI Pharma, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 61.40%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2024 | 61.40% | Infinity% |
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
The current Dividend Yield of MEI Pharma, Inc. (MEIP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
20.47%
5-year avg
12.28%
10-year avg
6.14%
MEI Pharma, Inc.’s Dividend Yield is less than Magenta Therapeutics, Inc. (0%), less than Kezar Life Sciences, Inc. (0%), less than Vincerx Pharma, Inc. (0%), less than Avenue Therapeutics, Inc. (0%), less than Assembly Biosciences, Inc. (0%), less than Neoleukin Therapeutics, Inc. (0%), less than Instil Bio, Inc. (0%), less than CytomX Therapeutics, Inc. (0%), less than Achilles Therapeutics plc (0%), less than Ocular Therapeutix, Inc. (0%), less than Spero Therapeutics, Inc. (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than HOOKIPA Pharma Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Inozyme Pharma, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than Revelation Biosciences, Inc. (0%), less than Zura Bio Limited (0%), less than Phio Pharmaceuticals Corp. (0%), less than ZyVersa Therapeutics, Inc. (0%), less than TransCode Therapeutics, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $42.44M | |
0% | $48.01M | |
0% | $6.41M | |
0% | $3.64M | |
0% | $97.63M | |
0% | $8.20M | |
0% | $142.46M | |
0% | $85.85M | |
0% | $46.65M | |
0% | $1.34B | |
0% | $51.47M | |
0% | $106.94M | |
0% | $18.44M | |
0% | $1.29B | |
0% | $192.08M | |
0% | $487.69M | |
0% | $2.93M | |
0% | $170.74M | |
0% | $2.97M | |
0% | $2.65M | |
0% | $2.49M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MEI Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MEI Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is MEI Pharma, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for MEI Pharma, Inc. (MEIP)?
What is the highest Dividend Yield for MEI Pharma, Inc. (MEIP)?
What is the 3-year average Dividend Yield for MEI Pharma, Inc. (MEIP)?
What is the 5-year average Dividend Yield for MEI Pharma, Inc. (MEIP)?
How does the current Dividend Yield for MEI Pharma, Inc. (MEIP) compare to its historical average?